Innovent Biologics Inc Net Asset Quality Index
Innovent Biologics Inc net asset quality index. Innovent Biologics Inc (6IB) has a Net Asset Quality Index of 51.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €37.35 Billion minus total liabilities of €17.99 Billion yields net assets of €19.36 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See Innovent Biologics Inc shareholders equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Innovent Biologics Inc (2016–2025)
Net asset quality index of Innovent Biologics Inc from 2016 to 2025. This chart shows how Innovent Biologics Inc's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the index stands at 51.8%, representing net assets of €19.36 Billion against total assets of €37.35 Billion EUR. Check 6IB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Innovent Biologics Inc Net Asset Quality Index by Year (2016–2025)
Innovent Biologics Inc net asset quality index by year from 2016 to 2025. The table below presents the year-by-year Net Asset Quality Index for Innovent Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market value of Innovent Biologics Inc.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.8% | €19.36 Billion | €37.35 Billion | €17.99 Billion | ▼ -8.9 pp |
| 2024 | 60.7% | €13.12 Billion | €21.60 Billion | €8.48 Billion | ▼ 0.0 pp |
| 2023 | 60.7% | €12.53 Billion | €20.63 Billion | €8.10 Billion | ▼ -0.3 pp |
| 2022 | 61.0% | €10.73 Billion | €17.59 Billion | €6.86 Billion | ▼ -2.6 pp |
| 2021 | 63.6% | €10.33 Billion | €16.24 Billion | €5.91 Billion | ▼ -10.6 pp |
| 2020 | 74.2% | €8.78 Billion | €11.83 Billion | €3.06 Billion | ▲ +8.4 pp |
| 2019 | 65.8% | €4.76 Billion | €7.23 Billion | €2.47 Billion | ▼ -2.8 pp |
| 2018 | 68.6% | €4.19 Billion | €6.11 Billion | €1.92 Billion | ▲ +134.6 pp |
| 2017 | -66.0% | €-1.62 Billion | €2.46 Billion | €4.08 Billion | ▼ -32.0 pp |
| 2016 | -34.0% | €-958.22 Million | €2.82 Billion | €3.77 Billion | — |